References
- MacNeil JR, Rubin L, Folaranmi T, Ortega-Sanchez IR, Patel M, Martin SW. Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64(41):1171–1176. doi:10.15585/mmwr.mm6441a3.
- Centers for Disease Control and Prevention. Enhanced meningococcal disease surveillance report. 2016 [ accessed 2018 Oct 1]. https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report.pdf.
- Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet. 2007;369(9580):2196–2210. doi:10.1016/S0140-6736(07)61016-2.
- Dastouri F, Hosseini AM, Haworth E, Khandaker G, Rashid H, Booy R. Complications of serogroup B meningococcal disease in survivors: a review. Infect Disord Drug Targets. 2015;14(3):205–212. doi:10.2174/1871526515999150320155614.
- Atkinson B, Gandhi A, Balmer P. History of meningococcal outbreaks in the United States: implications for vaccination and disease prevention. Pharmacotherapy. 2016;36(8):880–892. doi:10.1002/phar.1790.
- Grogan J, Roos K. Serogroup B meningococcus outbreaks, prevalence, and the case for standard vaccination. Curr Infect Dis Rep. 2017;19(9):30. doi:10.1007/s11908-017-0587-4.
- National Meningitis Association. Serogroup B meningococcal disease outbreaks on U.S. college campuses. [ accessed 2018 Jun 12]. http://www.nmaus.org/disease-prevention-information/serogroup-b-meningococcal-disease/outbreaks/.
- Folaranmi T, Rubin L, Martin SW, Patel M, MacNeil JR, Centers for Disease Control and Prevention. Use of serogroup B meningococcal vaccines in persons aged ≥10 years at increased risk for serogroup B meningococcal disease: recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64(22):608–612.
- MacNeil J, Advisory Committee on Immunization Practices. Epidemiology of serogroup B meningococcal disease. United States. [ accessed 2016 Oct 31]. http://www.nitag-resource.org/uploads/media/default/0001/02/243a06a67d8f4d6c08521e1d486325d2781c8b04.pdf.
- Garon D. From mening to syringe: outbreak of meningococcal disease at a New Jersey university. New Jersey: Department of Health; 2013. [ accessed 2018 Jun 12]. https://www.chicagohan.org/c/document_library/get_file?p_l_id=61826&folderId=88419&name=DLFE-499.pdf.
- Bilukha OO, Rosenstein N, National Center for Infectious Diseases, Centers for Disease Control and Prevention. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2005;54(RR–7):1–21.
- Bexsero (Meningococcal Group B Vaccine). Full prescribing information. Sovicille (Italy): GSK Vaccines, Srl; 2017.
- Trumenba (meningococcal group B vaccine). Full prescribing information. Philadelphia (PA): Pfizer Inc; 2018.
- US Food and Drug Administration. January 23, 2015, approval letter - Bexsero. [ accessed 2018 Jun 12]. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm431446.htm.
- US Food and Drug Administration. October 29, 2014 Approval Letter - TRUMENBA. [ accessed 2018 Jun 12]. https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm421034.htm.
- Soeters HM, McNamara LA, Whaley M, Wang X, Alexander-Scott N, Kanadanian KV, Kelleher CM, MacNeil J, Martin SW, Raines N, et al. Serogroup B meningococcal disease outbreak and carriage evaluation at a college - Rhode Island. MMWR Morb Mortal Wkly Rep. 2015;64(22):606–607.
- Fiorito TM, Bornschein S, Mihalakos A, Kelleher CM, Alexander-Scott N, Kanadanian KV, Raymond P, Sicard K, Dennehy PH. Rapid response to a college outbreak of meningococcal serogroup B disease: nation’s first widespread use of bivalent rLP2086 vaccine. J Am Coll Health. 2017;65(4):294–296. doi:10.1080/07448481.2017.1285772.
- Granoff DM, Pollard AJ, Harrison LH. 39 - Meningococcal capsular group B vaccines. In: Plotkin SA, Orenstein WA, Offit PA editors. Plotkin’s Vaccines. 7th ed. Philadelphia, PA: Elsevier; 2018.
- Centers for Disease Control and Prevention. Meningococcal disease. [ accessed 2018 Jun 12]. http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/mening.pdf.
- Centers for Disease Control and Prevention. Guidance for the evaluation and public health management of suspected outbreaks of meningococcal disease. [ accessed 2018 Apr 2]. https://www.cdc.gov/meningococcal/downloads/meningococcal-outbreak-guidance.pdf.
- Djibo S, Nicolas P, Alonso JM, Djibo A, Couret D, Riou JY, Chippaux JP. Outbreaks of serogroup X meningococcal meningitis in Niger 1995-2000. Trop Med Int Health. 2003;8(12):1118–1123. doi:10.1046/j.1360-2276.2003.01126.x.
- Klepac P, Bjornstad ON, Metcalf CJ, Grenfell BT. Optimizing reactive responses to outbreaks of immunizing infections: balancing case management and vaccination. PLoS One. 2012;7(8):e41428. doi:10.1371/journal.pone.0041428.
- Immunization Action Coalition. State information: meningococcal ACWY prevention mandates for colleges and universities. [ accessed 2018 Mar 14]. http://www.immunize.org/laws/menin.asp.
- National Meningitis Association. Meningococcal disease on U.S. College campuses, 2013-2017. [ accessed 2018 Mar 14]. http://www.nmaus.org/wp-content/uploads/2017/01/College-Cases-Map.pdf.
- Minot State University. Minot state to offer free meningococcal B vaccine. [ accessed 2018 Mar 14]. http://www.minotstateu.edu/pio/news/2018/03/minot-state-to-offer-free-meningococcal-b-vaccine.shtml.
- Esten K. Smith college meningitis case confirmed as same serogroup as umass outbreak. The Massachusetts Daily Collegian. [ accessed 2018 Mar 5]. https://dailycollegian.com/2018/03/update-smith-college-meningitis-case-confirmed-as-same-serogroup-as-umass-outbreak/.
- University of Massachesetts at Amherst. 2018 Update on Meningitis B [ accessed 2018 Jun 14]. http://www.umass.edu/meningitis.
- Terry L. OSU hit with 6th case of meningococcal disease; all students under 26 will need a vaccination. The Oregonian. [ accessed 2018 Feb 12]. http://www.oregonlive.com/health/index.ssf/2017/12/osu_hit_with_6th_case_of_menin.html.
- Hess D. Meet meningitis: is your student at risk? Kutztown University of Pennsylvania. [ accessed 2018 Mar 14]. https://www.kutztown.edu/Documents/health%20and%20wellness%20services/Website-MenBParentLetter.pdf.
- Centers for Disease Control and Prevention. Meningococcal outbreaks. [ accessed 2017 Oct 18]. https://www.cdc.gov/meningococcal/outbreaks/index.html.
- Smith College. Meningitis: CDC update and second vaccination clinic. [ accessed 2018 Jun 14]. https://www.smith.edu/news/meningitis-update-student-vaccination-clinic-thursday-march-1/.
- Anonychuk A, Woo G, Vyse A, Demarteau N, Tricco AC. The cost and public health burden of invasive meningococcal disease outbreaks: a systematic review. Pharmacoeconomics. 2013;31(7):563–576. doi:10.1007/s40273-013-0057-2.
- Jeppesen CA, Snape MD, Robinson H, Gossger N, John TM, Voysey M, Ladhani S, Okike IO, Oeser C, Kent A, et al. Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy. J Infect. 2015;71(1):43–52. doi:10.1016/j.jinf.2015.02.006.
- Yazdankhah SP, Caugant DA. Neisseria meningitidis: an overview of the carriage state. J Med Microbiol. 2004;53(Pt 9):821–832. doi:10.1099/jmm.0.45529-0.
- McNamara LA, Thomas JD, MacNeil J, Chang HY, Day M, Fisher E, Martin S, Poissant T, Schmink, SE, Steward-Clark E, et al. Meningococcal carriage following a vaccination campaign with MenB-4C and MenB-FHbp in response to a university serogroup B meningococcal disease outbreak-Oregon, 2015-2016. J Infect Dis. 2017; 216(9):1130–1140. doi:10.1093/infdis/jix446.
- Read RC, Baxter D, Chadwick DR, Faust SN, Finn A, Gordon SB, Heath PT, Lewis DJ, Pollard AJ, Turner DP, et al. Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial. Lancet. 2014; 384(9960):2123–2131. doi:10.1016/S0140-6736(14)60842-4.
- Patton ME, Stephens D, Moore K, MacNeil JR. Updated recommendations for use of MenB-FHbp serogroup B meningococcal vaccine — Advisory Committee on Immunization Practices, 2016. MMWR Morb Mortal Wkly Rep. 2017;66(19):509–513. doi:10.15585/mmwr.mm6619a6.
- Marshall HS, Richmond PC, Beeslaar J, Jiang Q, Jansen KU, Garces-Sanchez M, Martinon-Torres F, Szenborn L, Wysocki J, Eiden J, et al. Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis. 2017; 17(1):58–67. doi:10.1016/s1473-3099(16)30314-0.